We recently found that in patient-derived melanoma cell lines, those that were categorized as high in levels of Wnt5a and thus of an invasive phenotype, had dramatically less SOCE than non-invasive melanoma lines (Hooper et al., 2015). The gene discussed is WNT5A; the disease is melanoma.